GSK (LON:GSK) Hits New 12-Month Low – Here’s What Happened

GSK plc (LON:GSK)’s stock price reached a new 52-week low during mid-day trading on Tuesday . The company traded as low as GBX 1,360 ($17.50) and last traded at GBX 1,361.14 ($17.52), with a volume of 53444816 shares traded. The stock had previously closed at GBX 1,397 ($17.98).

Analyst Ratings Changes

Several research firms have commented on GSK. Berenberg Bank reaffirmed a “buy” rating and set a GBX 1,820 ($23.42) price target on shares of GSK in a research report on Tuesday, September 10th. Shore Capital reiterated a “buy” rating on shares of GSK in a research report on Wednesday, August 28th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a GBX 1,850 ($23.81) price target on shares of GSK in a research note on Tuesday, September 3rd. Finally, JPMorgan Chase & Co. restated an “underweight” rating on shares of GSK in a research note on Monday, July 29th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of GBX 1,842.50 ($23.71).

GSK Trading Down 0.4 %

The company has a debt-to-equity ratio of 123.04, a quick ratio of 0.73 and a current ratio of 0.82. The stock has a market capitalization of £55.35 billion, a PE ratio of 1,204.87, a price-to-earnings-growth ratio of 1.24 and a beta of 0.31. The business’s 50-day moving average is GBX 1,507.18 and its two-hundred day moving average is GBX 1,581.86.

GSK Dividend Announcement

The company also recently declared a dividend, which will be paid on Thursday, January 9th. Stockholders of record on Thursday, November 14th will be paid a dividend of GBX 15 ($0.19) per share. The ex-dividend date is Thursday, November 14th. This represents a dividend yield of 1.03%. GSK’s dividend payout ratio (DPR) is 5,309.73%.

Insider Buying and Selling

In other GSK news, insider Jonathan Symonds acquired 7,150 shares of the stock in a transaction on Wednesday, October 30th. The shares were bought at an average price of GBX 1,394 ($17.94) per share, with a total value of £99,671 ($128,260.20). In related news, insider Elizabeth (Liz) McKee Anderson purchased 446 shares of the business’s stock in a transaction dated Monday, September 23rd. The stock was acquired at an average price of GBX 2,051 ($26.39) per share, for a total transaction of £9,147.46 ($11,771.28). Also, insider Jonathan Symonds acquired 7,150 shares of GSK stock in a transaction that occurred on Wednesday, October 30th. The stock was bought at an average price of GBX 1,394 ($17.94) per share, with a total value of £99,671 ($128,260.20). Insiders bought 7,604 shares of company stock valued at $10,893,038 over the last ninety days. Corporate insiders own 1.61% of the company’s stock.

GSK Company Profile

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.